William L. Carroll

Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia